-+ 0.00%
-+ 0.00%
-+ 0.00%

Addex Therapeutics files Form 3 initial beneficial ownership statement; Principal Accounting Officer Lenaic Nathanael Teyssedou reports stock options with exercise prices of $0.166 and $0.055

Reuters·03/25/2026 20:03:05

Please log in to view news